Rationale: Percutaneous cardiopulmonary support (PCPS) using extracorporeal membrane oxygenation (ECMO) is widely used in the critical patients with cardiopulmonary collapse. It is a representative blood-consuming procedure. In limited situations in which the option of blood transfusion is unavailable, there is no general agreement as to whether ECMO is contraindicated.
Introduction
Percutaneous cardiopulmonary support (PCPS) using extracorporeal membrane oxygenation (ECMO) has been widely used in patients with cardiopulmonary collapse. [1] [2] [3] Almost all patients undergoing ECMO procedure receive multiple and massive blood transfusions because of procedural blood loss, frequent laboratory monitoring, and hemolysis. Especially, an amount of blood loss is unavoidable during the ECMO removal due to the considerable discarded blood within the ECMO circuit. Complicating the utilization of ECMO is if a patient cannot receive blood transfusions due to any cause including religious grounds or a shortage of blood supply due to a rare blood type. [4] [5] [6] We managed a Jehovah Witness patient with severe hypoxia due to massive pulmonary thromboembolism using ECMO. Based on religious grounds, the family refused any type of blood transfusions throughout the entire hospital course. We successfully removed ECMO apparatus by blood-sparing technique of recycling blood in the circuit.
Case
A 61-year-old male came to the emergency room due to loss of consciousness and severe dyspnea. Upon arrival, he developed a generalized seizure. Subsequently, cardiac arrest occurred during preparation for brain imaging. A return of spontaneous Editor: N/A. Informed written consent was obtained from the guardian for publication of this case report and accompanying images.
The authors have no conflicts of interests to disclose. circulation was attained 3 minutes after initiation of cardiopulmonary resuscitation. There was no specific medical history such as hypertension and diabetes. Social history taking revealed that the patient was a Jehovah Witness. The patient had been suffering from a painful left thigh for several days. A chest computed tomography scan revealed large-sized filling defects in both main pulmonary arteries suggesting massive pulmonary thromboembolism ( Fig. 1 ). The vital signs were improved with inotropic support. However, severe hypoxia was not corrected despite intensive mechanical ventilation with high oxygen flow. For respiratory support, PCPS using ECMO during intensive care was considered. The guardian agreed to the ECMO procedure but strongly refused any type of blood transfusion including autotransfusion in deference to the patient's religious beliefs. After receiving informed consent, emergent veno-venous type ECMO (Capiox EBS, Terumo, Tokyo, Japan) was applied in catheterization room (Fig. 2 ). Simultaneously performed coronary angiography showed chronic total occlusion of the proximal-to-mid segment of the left anterior descending artery with good collateral flow from the distal segment of the right coronary artery (Rentrop grading of II-III/III) ( Fig. 3 ). Immediately after ECMO procedure, the level of Hb and Hct decreased from 15.8 g/dl and 46.8% to 11.7 g/dl and 36.5%, respectively. On hospital day 3, the level of Hb and Hct was gradually decreased to 7.7 g/dl and 23.6%, respectively. The global oxygenation was recovered with minimal support by ECMO. The decision was made to remove the ECMO apparatus.
In order to minimize additional blood loss, blood-sparing strategy during ECMO circuit removal should be attempted. Our blood-loss minimizing decannulation techniques were as follows: After the access cannula was clamped by hemostat, a total of 600 cc of saline was slowly infused via access cannula port to the EMCO circuit until the blood in entire circuit including the both cannulae, the pump, and the membrane chamber was replaced with saline. Then, the venous return cannula was clamped and both cannulae were carefully removed at 0 rpm of motor speed (Fig. 4 ). There was no evidence of air and/or thrombus entering the circuit during the entirety of the ECMO removal procedure. Moreover, there was no significant change in patient hemodynamics before and after ECMO removal. Several hours later, the level of Hb and Hct was not changed. Two days after ECMO removal, the level of Hb and Hct was increase up to 9.2 g/dl and 30.0%, respectively (Fig. 5 ). Informed consent was given for publication of the case by the patient's guardian.
Discussions
PCPS using ECMO has been widely used in patients with intractable cardiogenic shock and/or brain hypoxia in an emergent setting. ECMO is considered as a representative blood-consuming procedure. During initial cannulation and maintenance of ECMO, frequent blood sampling is required to monitor the hematologic and metabolic status including anemia, acid-base balance, and thrombotic status. [7] Especially at weaning and decannulation, another massive blood loss is inevitable because the considerable blood in the removed circuit usually discarded. [1, 7] For these reason, blood product transfusion is crucial during ECMO support period. Regretfully, there is no specific information or consensus in current guidelines for blood-saving during ECMO removal. [1] Blood transfusion is often limited in some clinical situations such as a rare blood type or patient refusal due to various causes. From this social and medical standpoint, it is difficult to manage Jehovah Witness patients because they strongly refuse receiving any type of blood transfusion. Even in the special clinical situation, treatment strategies need to be individualized depending on the patients' clinical situation. [4, 5] Moreover, the appropriate medical therapies, care, and consideration should be given in order to respect their individual autonomy. [8] To overcome this clinical handicap, several techniques have been proposed in previous literature; Iron supplementation, human recombinant erythropoietin injection, and bloodless cardiac surgery with autologous transfusion etc. in the surgical management of Jehovah Witness patient. [5, 6] In the present case, we intended to recycle blood in the ECMO circuit including both access and return cannula and within the membrane chamber. ECMO circuit in our institute was designed to be filled with 500 cc of blood which is estimated as 2 or 3 units of packed red blood cell. [7] Owing to the technique, the level of Hb and Hct was increased without any transfusion at second day after ECMO circuit removal.
In conclusion, our blood-sparing removal technique of ECMO circuit appears to be feasible and led to no significant adverse impact on the patient's hemodynamic status. Our technique might be helpful for critical patients who cannot receive blood transfusion due to any cause. Further clinical trials are warranted to validate this technique. 
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